What is dexamethasone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dexamethasone: A Potent Synthetic Glucocorticoid

Dexamethasone is a potent, long-acting synthetic glucocorticoid with significant anti-inflammatory, immunosuppressive, and anti-allergic properties that is approximately 25 times more potent than short-acting corticosteroids like hydrocortisone. 1

Pharmacological Properties

  • Potency: 25 times more potent than hydrocortisone with a half-life of 36-72 hours 2
  • Duration: Long-acting with a half-life of 36-72 hours 2
  • Equivalent doses: 0.1 mg dexamethasone equals 10 mg hydrocortisone; 8 mg dexamethasone equals 200 mg hydrocortisone 2
  • Formulations: Available as oral tablets, injectable solutions (IV/IM), and other preparations 3, 4
  • Mineralocorticoid activity: Lacks significant mineralocorticoid activity, making it unsuitable as sole therapy for primary adrenal insufficiency 2

Clinical Applications

Oncology

  • Chemotherapy-induced nausea/vomiting: Standard antiemetic prophylaxis in moderate to high emetic risk chemotherapy 5
    • High emetic risk: Dexamethasone 20 mg day 1, then 8 mg days 2-4
    • Moderate emetic risk: Dexamethasone 8 mg on day 1 (single dose)
    • Low emetic risk: Dexamethasone 8 mg (single dose) 5

Hematologic Malignancies

  • Acute Lymphoblastic Leukemia (ALL): Core component of induction therapy alongside vincristine, anthracyclines, and asparaginase 5
    • Preferred over prednisone in many protocols due to better CNS penetration
    • Reduces risk of CNS relapse and improves event-free survival 5
    • Dosing typically 6 mg/m² daily for 28 days in pediatric protocols 5

Immunotherapy Complications

  • Cytokine Release Syndrome (CRS):
    • Grade 2: Dexamethasone 10 mg IV every 12-24 hours 5
    • Grade 3-4: Dexamethasone 10 mg IV every 6 hours 5
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS):
    • Grade 2: Dexamethasone 10 mg IV, may repeat every 6-12 hours if no improvement
    • Grade 3: Dexamethasone 10 mg IV every 6 hours
    • Grade 4: High-dose methylprednisolone 1000 mg/day 5

Infectious Diseases

  • Bacterial Meningitis: Adjunctive therapy to reduce neurological sequelae and hearing loss 5
    • Adults: 10 mg IV every 6 hours for 4 days
    • Children: 0.15 mg/kg IV every 6 hours for 4 days
    • Should be started before or with the first dose of antibiotics, but can be started up to 4 hours after antibiotics 5
    • Most beneficial for pneumococcal and H. influenzae meningitis 5

Perioperative Use

  • PONV Prevention: Single dose of 4-5 mg has similar efficacy to 8-10 mg 5
    • The DREAMS trial confirmed that a single 8 mg dose reduced PONV for up to 72 hours 5

Side Effects and Risks

  • Short-term use: Generally well-tolerated with minimal adverse effects 2

    • Hyperglycemia
    • Sleep disturbances
    • Epigastric burning sensation
  • Long-term use: Significant adverse effects 6

    • Weight changes (typically weight loss in animal studies) 6
    • Metabolic disturbances (hyperglycemia, lipid abnormalities) 6
    • Bone metabolism abnormalities (reduced alkaline phosphatase) 6
    • Protein catabolism and muscle wasting 6
    • Immunosuppression

Special Considerations

  • In ALL treatment, dexamethasone is associated with higher risk of osteonecrosis, infection, and induction mortality compared to prednisone, despite better CNS penetration 5
  • For short-term use (<1 week), dexamethasone can be discontinued rapidly without tapering 2
  • For longer use (>3 weeks), gradual tapering is recommended to prevent adrenal insufficiency 2
  • When used for bacterial meningitis, dexamethasone should be discontinued if the causative organism is determined not to be H. influenzae or S. pneumoniae 5

Dosing Recommendations

  • Single daily dosing is possible due to long half-life and excellent bioavailability 2
  • Tapering schedule for prolonged use (from 16 mg): 12 mg/day for 2-3 days → 8 mg/day for 2-3 days → 4 mg/day for 2-3 days → 2 mg/day for 2-3 days before discontinuation 2
  • Dose adjustments may be needed for patients taking CYP3A4 inducers or those who are obese 2

Dexamethasone's potency, long half-life, and minimal mineralocorticoid effects make it a valuable therapeutic option across multiple medical specialties, but its use must be balanced against potential adverse effects, particularly with prolonged administration.

References

Research

A different look at corticosteroids.

American family physician, 1998

Guideline

Dexamethasone Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.